Fresenius: Growth of Home Dialysis is NINE Times that of In-Center HD
With more than 25,000 home dialysis patients and impressive growth, the Fresenius investment in innovation to improve care appears to be paying off. Executive VP and CMO Robert Kossmann, MD, noted that “The goals of the executive order are aligned with our existing strategy and our company’s commitment to increasing the accessibility of home therapies for our patients.”
Read the full article » | Posted 12-10-2019
Related Articles
- Watch a 2-minute video of Dr. Brigitte Schiller describing a paper on nocturnal home HD Posted 08-21-2026
- The Quanta Dialysis System for home HD is the first FDA 510(k) approved machine that offers high (500 mL/min) dialysate flow Posted 08-21-2026
- The American Kidney Fund’s Kidney Action Week: Future of Kidney Care is September 8-10. Posted 08-21-2026
- On August 9, CMS published “Regulatory Alignment for Predictable and Immediate Device Coverage Pathway (CMS-3487-NC) Procedural Notice Inviting Comment.” Posted 08-21-2026